trial · primary record
Dapagliflozin (10mg Tab)
Prostate Cancer
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 68 |
| Primary completion | 2030-04-30 |
| Primary endpoint | Radiographic Progression-Free Survival (rPFS) |
| Registry ID | NCT07310433 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:40:56.903Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07310433
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- DAPAGLIFLOZIN · approval
- DAPAGLIFLOZIN · approval
- Dapagliflozin · compound